Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
94.2M
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
30.7M
-
Shares change
-
+307K
-
Total reported value, excl. options
-
$465M
-
Value change
-
+$5.52M
-
Number of buys
-
32
-
Number of sells
-
-35
-
Price
-
$15.28
Significant Holders of Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) as of Q1 2021
89 filings reported holding CRNX - Crinetics Pharmaceuticals, Inc. - Common Stock as of Q1 2021.
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.7M shares
of 94.2M outstanding shares and own 32.63% of the company stock.
Largest 10 shareholders include FMR LLC (4.94M shares), PERCEPTIVE ADVISORS LLC (3.66M shares), ORBIMED ADVISORS LLC (2.75M shares), Vivo Capital, LLC (2.21M shares), BlackRock Inc. (2.17M shares), Versant Venture Management, LLC (2.03M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (2M shares), 5AM Venture Management, LLC (1.36M shares), Point72 Asset Management, L.P. (1.28M shares), and VANGUARD GROUP INC (1.16M shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.